A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

被引：0
|
作者：
Hu, Ziyi [1 ]
Zhou, Tingting [1 ]
Wu, Fangrong [1 ]
Lin, Fan [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Nanjing Med Univ, Sch Basic Med Sci, Dept Cell Biol, Nanjing, Peoples R China
[2] Nanjing Med Univ, Inst Brain Tumors, Nanjing, Peoples R China
[3] Nanjing Med Univ, Key Lab Rare Metab Dis, Nanjing, Peoples R China
[4] Nanjing Med Univ, Affiliated Canc Hosp, Nanjing, Peoples R China
[5] Key Lab Human Funct Genom Jiangsu Prov, Nanjing, Peoples R China
来源：
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS | 2021年 / 169期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.3791/62312
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
The glioma stem cells (GSCs) are a small fraction of cancer cells which play essential roles in tumor initiation, angiogenesis, and drug resistance in glioblastoma (GBM), the most prevalent and devastating primary brain tumor. The presence of GSCs makes the GBM very refractory to most of individual targeted agents, so high-throughput screening methods are required to identify potential effective combination therapeutics. The protocol describes a simple workflow to enable rapid screening for potential combination therapy with synergistic interaction. The general steps of this workflow consist of establishing luciferase-tagged GSCs, preparing matrigel coated plates, combination drug screening, analyzing, and validating the results.
引用
收藏
页数：10
相关论文
共 50 条
  • [21] Clinical Trial in a Dish Using Patient-Derived Induced Pluripotent Stem Cells to Identify Risks of Drug-Induced Cardiotoxicity
    Lam, Chi Keung
    Wu, Joseph C.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (03) : 1019 - 1031
  • [22] Patient heal thyself: modeling and treating neurological disorders using patient-derived stem cells
    Ess, Kevin C.
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2013, 238 (03) : 308 - 314
  • [23] Assessment of ALDH activity in neuroblastoma patient-derived xenograft cells as a potential marker of neuroblastoma stem cells
    Persson, Camilla
    von Stedingk, Kristoffer
    Bexell, Daniel
    Merselius, My
    Braekeveldt, Noemie
    Pahlman, Sven
    Wigerup, Caroline
    CANCER RESEARCH, 2017, 77
  • [24] Transcriptome profiles of cancer stem-like cells in patient-derived diffuse intrinsic pontine glioma (DIPG)
    Galban, Stefanie
    Espinoza, Carlos
    Bedi, Karan
    Maachani, Uday B.
    Souweidane, Mark M.
    Ljungman, Mats
    Van Dort, Marcian
    Ross, Brian D.
    CANCER RESEARCH, 2018, 78 (13)
  • [25] THE EFFECT OF INTERSTITIAL FLUID FLOW AND ASTROCYTES/MICROGLIA ON INVASION, PROLIFERATION AND STEMNESS OF PATIENT-DERIVED GLIOMA STEM CELLS
    Atay, Naciye
    Yuan, Jessica
    Cornelison, Chase
    Munson, Jennifer
    NEURO-ONCOLOGY, 2020, 22 : 216 - 216
  • [26] Molecular characteristics of single patient-derived glioma stem-like cells from primary and recurrent glioblastoma
    Shi, Jia
    Dong, Xuchen
    Han, Wei
    Zhou, Peng
    Liu, Liang
    Wang, Haiyang
    Jiang, Qianqian
    Li, Haoran
    Cheng, Shan
    Li, Suwen
    Yuan, Jiaqi
    Qian, Zhiyuan
    Dong, Jun
    ANTI-CANCER DRUGS, 2022, 33 (01) : E381 - E388
  • [27] Chemosensitivity of Patient-Derived Cancer Stem Cells Identifies Colorectal Cancer Patients with Potential Benefit from FGFR Inhibitor Therapy
    Yamamoto, Takehito
    Miyoshi, Hiroyuki
    Kakizaki, Fumihiko
    Maekawa, Hisatsugu
    Yamaura, Tadayoshi
    Morimoto, Tomonori
    Katayama, Toshiro
    Kawada, Kenji
    Sakai, Yoshiharu
    Taketo, M. Mark
    CANCERS, 2020, 12 (08) : 1 - 19
  • [28] Emerging Prospects for the Study of Colorectal Cancer Stem Cells using Patient-derived Organoids
    Ding, Ling
    Yang, Yuning
    Lu, Qin
    Cao, Zhiyun
    Weygant, Nathaniel
    CURRENT CANCER DRUG TARGETS, 2022, 22 (03) : 195 - 208
  • [29] Studying Abnormal Chromosomal Diseases Using Patient-Derived Induced Pluripotent Stem Cells
    Hayashi, Yohei
    Takami, Miho
    Matsuo-Takasaki, Mami
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2020, 14
  • [30] Using patient-derived induced pluripotent stem cells to model multiple epiphyseal dysplasia
    Woods, S.
    Harley, P.
    Soul, J.
    Kamprom, N.
    Bates, N.
    Wang, Q.
    Mortier, G.
    Hardingham, T.
    Kimber, S. J.
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2018, 99 (06) : A52 - A52
12345